Clinical Trials in Scottsdale, Arizona

SW-682 in Advanced Solid Tumors

NCT ID: NCT06251310

This clinical trial is studying a new treatment called SW-682 for adults with advanced solid tumors, which are types of cancers that have spread or cannot be removed through surgery. It is specific...

Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)

NCT ID: NCT06464926

The NAVIGATE trial is studying whether the Enterra® Therapy System can help reduce nausea and vomiting in patients who have been dealing with chronic nausea for more than six months, even when trad...

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients

NCT ID: NCT06496178

This clinical trial is studying a new treatment called petosemtamab for patients with head and neck squamous cell carcinoma (HNSCC) who have already received other treatments. It aims to find out i...

SIMPLAAFY Clinical Trial

NCT ID: NCT06521463

The SIMPLAAFY Clinical Trial is studying the safety and effectiveness of two single-drug treatments compared to a combination of two antiplatelet drugs for patients who have received a WATCHMAN FLX...

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NCT ID: NCT06532279

This clinical trial is studying whether adding a drug called BMX-001 to the usual treatment for head and neck cancer can help reduce a painful side effect called oral mucositis, which causes mouth ...

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

NCT ID: NCT06698458

This clinical trial is exploring a new treatment for pancreatic cancer that combines a special type of radiation therapy called Alpha DaRT with chemotherapy. The goal is to see if this combination ...

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

NCT ID: NCT03418038

This clinical trial is studying the combined effect of ascorbic acid (a form of vitamin C) and chemotherapy on patients with certain types of lymphoma that have either come back after treatment or ...

Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial

NCT ID: NCT05497804

The REACH Trial is a clinical study exploring the effectiveness of a combination of chemotherapy drugs to treat high-risk multiple myeloma, which is a type of blood cancer. This trial specifically ...

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

NCT ID: NCT06551324

This clinical trial, called MEVPRO-1, is looking at a new medicine called PF-06821497 (Mevrometostat) to see if it can help men with metastatic castrate-resistant prostate cancer (mCRPC) who have p...

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

NCT ID: NCT06856577

This clinical trial is studying a new treatment called Ixoberogene Soroparvovec (Ixo-vec) for people with a specific eye condition known as neovascular age-related macular degeneration (nAMD), whic...

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

NCT ID: NCT05651932

This clinical trial is studying a new medication designed to treat adults with relapsed or refractory multiple myeloma, a type of blood cancer that has not responded to previous treatments. The dru...

Gastroparesis Registry 4

NCT ID: NCT05846802

The Gastroparesis Registry 4 (GpR4) is a study designed to learn more about two conditions: gastroparesis, which affects how the stomach empties, and functional dyspepsia, which involves discomfort...

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT05919264

This clinical trial, called FOG-001, is investigating a new treatment for people with advanced or metastatic solid tumors, which are types of cancer that have spread beyond their original site. The...

Improving Outcomes in PICS With Home-Based Program of Rehabilitation and Health Coaching

NCT ID: NCT06184308

This clinical trial is studying a home-based rehabilitation program designed to help patients who are experiencing post-intensive care syndrome (PICS). PICS can happen to individuals who have spent...

A Study of SGN-MesoC2 in Advanced Solid Tumors

NCT ID: NCT06466187

This clinical trial is looking at a new treatment called SGN-MesoC2 for people with advanced solid tumors, which are types of cancer that start in organs like the lungs, pancreas, or ovaries. The s...

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

NCT ID: NCT05270213

This clinical trial is studying a new treatment called RBS2418 for patients with advanced cancer that cannot be surgically removed or has come back after treatment. RBS2418 is designed to help the ...

Long-Term Follow-up Study

NCT ID: NCT05332054

J-Valve Transfemoral Pivotal Study

NCT ID: NCT06455787

The J-Valve Transfemoral Pivotal Study is researching a new treatment option for patients with severe aortic valve regurgitation, a condition where the heart's aortic valve does not close properly,...

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

NCT ID: NCT06467084

This clinical trial is studying a new treatment called Sebetralstat (KVD900) for children aged 2 to 11 who have a condition called Hereditary Angioedema (HAE) Type I or II. HAE is a genetic disorde...

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

NCT ID: NCT05478304

The Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial is a study designed to see if a specific procedure, called left atrial appendage exclusion (LAAE), can help prevent strok...